bexarotene
Generic: bexarotene
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
bexarotene
Generic Name
bexarotene
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE, LIQUID FILLED
Routes
Active Ingredients
bexarotene 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0591-2832
Product ID
0591-2832_76dd1532-aa15-4e10-a26f-3cb25fbf8c1f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209931
Listing Expiration
2026-12-31
Marketing Start
2021-11-11
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05912832
Hyphenated Format
0591-2832
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bexarotene (source: ndc)
Generic Name
bexarotene (source: ndc)
Application Number
ANDA209931 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 75 mg/1
Packaging
- 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "76dd1532-aa15-4e10-a26f-3cb25fbf8c1f", "openfda": {"nui": ["N0000175607", "M0018962"], "unii": ["A61RXM4375"], "rxcui": ["308725"], "spl_set_id": ["3292c63c-052f-4f28-b739-530a86e660bf"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01)", "package_ndc": "0591-2832-01", "marketing_start_date": "20211111"}], "brand_name": "bexarotene", "product_id": "0591-2832_76dd1532-aa15-4e10-a26f-3cb25fbf8c1f", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "0591-2832", "generic_name": "bexarotene", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bexarotene", "active_ingredients": [{"name": "BEXAROTENE", "strength": "75 mg/1"}], "application_number": "ANDA209931", "marketing_category": "ANDA", "marketing_start_date": "20211111", "listing_expiration_date": "20261231"}